This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Current and new antitumor necrosis factor agents in perspective
-
Correspondence: Ravinder N Maini r.maini@imperial.ac.uk
Arthritis Res Ther 2004, 6(Suppl 2):S1-S2 doi:10.1186/ar994
No comments have yet been made on this article.